Survival Predictors of 177Lu-Dotatate Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Progressive Well-Differentiated Neuroendocrine Tumors (NETS).

Swiha Mina M.,Sutherland Duncan E. K.,Sistani Golmehr,Khatami Alireza,Abazid Rami M.,Mujoomdar Amol,Wiseman Daniele P.,Romsa Jonathan G.,Reid Robert H.,Laidley David T.

Journal of cancer research and clinical oncology（2021）

引用 10|浏览12

暂无评分

关键词

Survival predictors,Prognostic factors,Lu-Dotatate,PRRT,Neuroendocrine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要